search
Back to results

Erb:Yag Laser Versus Pelvic Floor Training for the Treatment of Women With Mild to Moderate Stress Urinary Incontinence (EFFECT)

Primary Purpose

Stress Urinary Incontinence

Status
Unknown status
Phase
Not Applicable
Locations
Chile
Study Type
Interventional
Intervention
Erbium Yag Laser
Pelvic Floor Training
Sponsored by
Pontificia Universidad Catolica de Chile
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stress Urinary Incontinence

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Mild to Moderated Stress Urinary Incontinence

Exclusion Criteria:

  • Mixed Urinary incontinence
  • Pelvic organ prolase greater than stage 2
  • Previous surgery for stress urinary incontinence and/or pelvic organ prolapse
  • Severe Stress urinary incontinence

Sites / Locations

  • Hospital Clinico de La FloridaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Erbium:Yag Laser

Pelvic floor training

Arm Description

Patients allocated to the erbium:yag laser are going to undergo 2 sessions of vaginal laser, separated by one month each other.

Patients allocated to pelvic floor training, are goin to undergo 10 sessions of pelvic floor exercises coached by an expert physiotherapist.

Outcomes

Primary Outcome Measures

Change in quality of life
In order to measure quality of life, we are going to use the International Consultation on Incontinence Questionnaire Short Form (ICQI-SF), validate to spanish and in Chile. A higher score in this scale means a worse outcome for the patient.

Secondary Outcome Measures

Pad test
A 24 h Pad test will be applied. The pad will be weighted after 24 h of use and the difference between the dry pad and the wet pad is going to be recorded. A great difference means a worse outcome for the patient.

Full Information

First Posted
August 1, 2020
Last Updated
January 11, 2021
Sponsor
Pontificia Universidad Catolica de Chile
search

1. Study Identification

Unique Protocol Identification Number
NCT04705285
Brief Title
Erb:Yag Laser Versus Pelvic Floor Training for the Treatment of Women With Mild to Moderate Stress Urinary Incontinence
Acronym
EFFECT
Official Title
Erbium:Yag Laser Versus Pelvic Floor Training for the Treatment of Women With Mild to Moderate Stress Urinary Incontinence: a Pilot Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
January 2021
Overall Recruitment Status
Unknown status
Study Start Date
May 15, 2019 (Actual)
Primary Completion Date
June 21, 2021 (Anticipated)
Study Completion Date
September 15, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Pontificia Universidad Catolica de Chile

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This is a pilot study to assess the feasibility and safety to run a randomized controlled trial that compared the effectivity of erbium:yag vaginal laser versus pelvic floor training in women with mild to moderate stress urinary incontinence.
Detailed Description
This pilot study attempts to demonstrated the feasibility and security to run a randomized controlled study that compared the effectivity of erbium:yag laser used vaginally versus pelvic floor training, coached by a physiotherapist expert in pelvic floor disorders. Patients are going to be randomized to pelvic floor exercises (10 sessions) or erbium:yag laser (2 sessions), and assess the results at 6 and 12 moths later on.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stress Urinary Incontinence

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
randomized controlled trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Erbium:Yag Laser
Arm Type
Experimental
Arm Description
Patients allocated to the erbium:yag laser are going to undergo 2 sessions of vaginal laser, separated by one month each other.
Arm Title
Pelvic floor training
Arm Type
Active Comparator
Arm Description
Patients allocated to pelvic floor training, are goin to undergo 10 sessions of pelvic floor exercises coached by an expert physiotherapist.
Intervention Type
Device
Intervention Name(s)
Erbium Yag Laser
Intervention Description
Subjets in the laser arm will undergo 2 sessions of vaginal erbium-yag laser, separated by a month
Intervention Type
Behavioral
Intervention Name(s)
Pelvic Floor Training
Intervention Description
Patients allocated to pelvic floor training, are goin to undergo 10 sessions of pelvic floor exercises coached by an expert physiotherapist
Primary Outcome Measure Information:
Title
Change in quality of life
Description
In order to measure quality of life, we are going to use the International Consultation on Incontinence Questionnaire Short Form (ICQI-SF), validate to spanish and in Chile. A higher score in this scale means a worse outcome for the patient.
Time Frame
The questionnaire will be applied at baseline, 6 month and 1 year
Secondary Outcome Measure Information:
Title
Pad test
Description
A 24 h Pad test will be applied. The pad will be weighted after 24 h of use and the difference between the dry pad and the wet pad is going to be recorded. A great difference means a worse outcome for the patient.
Time Frame
at baseline, 6 month and 1 year

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Mild to Moderated Stress Urinary Incontinence Exclusion Criteria: Mixed Urinary incontinence Pelvic organ prolase greater than stage 2 Previous surgery for stress urinary incontinence and/or pelvic organ prolapse Severe Stress urinary incontinence
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Victor A Miranda, MD
Phone
+56988291697
Email
vmirandah@med.puc.cl
First Name & Middle Initial & Last Name or Official Title & Degree
Sebastian Viguera, MD
Phone
+56993316816
Email
sebastian.viguera@gmail.com
Facility Information:
Facility Name
Hospital Clinico de La Florida
City
Santiago
Country
Chile
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sebastian Viguera, MD
Phone
+56993316816
Email
sebastian.viguera@gmail.com
First Name & Middle Initial & Last Name & Degree
Victor Miranda, MD
First Name & Middle Initial & Last Name & Degree
Sebastian Viguera, MD
First Name & Middle Initial & Last Name & Degree
Sarita Donoso
First Name & Middle Initial & Last Name & Degree
Gloria Alonso

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Erb:Yag Laser Versus Pelvic Floor Training for the Treatment of Women With Mild to Moderate Stress Urinary Incontinence

We'll reach out to this number within 24 hrs